Main Session: New Drugs and Novel Mechanisms of Action in Treating Patients with Multiple Myeloma

What are the mechanisms of action of the new and emerging agents for multiple myeloma?

Jonathan Kaufman, MD
The Winship Cancer Institute of Emory University


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.